NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Diagnostics & Research · USD

Mettler-Toledo International Inc. (MTD) Stock Analysis

Mettler-Toledo International Inc. (MTD) is a Diagnostics & Research stock listed on NYSE and quoted in US Dollar.

MTD

$1,345.26

−$10.97 (−0.81%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MTD with… →

MTD Key Statistics

As of Sep 4, 2026
Trading
Open
$1,341.57
Previous Close
$1,356.23
Day's Range
1,339.09–1,358.78
52-Week Range
1,023.05–1,525.17
Volume
103.00K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.22
Valuation
Market Cap
$26.95B
P/E Ratio
30.33
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
26.01
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.52
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.52
EPS (ttm)Profit attributable to each share over the last twelve months.
44.35
Financials (FY)
Revenue (FY)
$4.03B+3.98%
Net Income (FY)
$869.19M+0.70%
Profit marginThe share of revenue left as profit after all costs and taxes.
21.91%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
20.04M
1-Year Return
+4.46%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
189.88K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MTD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−3.51%
2025+13.93%
2024+0.88%
2023−16.08%
2022−14.83%
2021+48.92%
2020+43.67%
2019+40.26%
2018−8.71%
2017+48.01%
2016 (partial year)+5.05%

As of September 4, 2026.

MTD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.03B$869.19M21.6%
2024$3.87B$863.14M22.3%
2023$3.79B$788.78M20.8%
2022$3.92B$872.50M22.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.03B$2.39B$1.12B$869.19M21.6%
2024$3.87B$2.33B$1.13B$863.14M22.3%
2023$3.79B$2.24B$1.08B$788.78M20.8%
2022$3.92B$2.31B$1.13B$872.50M22.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MTD Valuation vs Diagnostics & Research Median

Median of 49 stocks
MetricMTDDiagnostics & Research medianvs median
P/E30.3333.088% below
P/S ratio6.524.9931% above
Profit margin21.91%0.00%21.9 pts above

Medians across 49 Diagnostics & Research stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Mettler-Toledo International Inc. (MTD) carries a market capitalisation of $26.95B. The company sits in the Healthcare sector, in the Diagnostics & Research industry. The company reports 16,600 employees.

Over the past 52 weeks the price has ranged from $1,023.05 to $1,525.17. MTD last closed at $1,345.26 on September 4, 2026. That is −$10.97 (−0.81%) against the previous close. The latest close sits 31.5% above that 52-week low.

Financial Health

In fiscal 2025, Mettler-Toledo International Inc. reported revenue of $4.03B. That is +3.98% against the prior fiscal year, when revenue was $3.87B. Net income for the same year was $869.19M. That is +0.70% against the prior fiscal year. The reported profit margin is 21.91%. That is 21.9 percentage points above the Diagnostics & Research median of 0%. Earnings per share on a trailing basis come to 44.35.

Across the 4 fiscal years on file, revenue moves from $3.92B in 2022 to $4.03B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 30.33 times earnings. That is 8.31% below the Diagnostics & Research median of 33.08. The forward P/E on file is 26.01. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.52. Measured against sales, the shares trade at 6.52 times revenue. On price-to-sales that is 30.66% above the Diagnostics & Research median of 4.99. 49 Diagnostics & Research companies report these metrics, and the medians quoted come from that group.

The reported beta is 1.22. Annualized volatility over the trailing 10 years is 29.86%. Over the trailing twelve months the price has returned +4.46%. Across 10 years the annualized return works out at +12.85%.

Growth & Income

The record shows no dividend for MTD.

The strongest complete calendar year on file is 2021 at +48.92%; the weakest is 2023 at −16.08%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is −3.51%.

Peer Comparison

Mettler-Toledo International Inc. (MTD) operates in the Diagnostics & Research industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Mettler-Toledo International Inc. MTD $26.95B 30.3
Thermo Fisher Scientific Inc. TMO $226.94B 33.0
Danaher Corporation DHR $145.98B 37.0
Natera, Inc. NTRA $47.31B —

The Diagnostics & Research industry average P/E ratio is 33.1x. Mettler-Toledo International Inc. trades at a P/E of 30.3.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Diagnostics & Research Stocks

TMO

Thermo Fisher Scientific Inc.

$226.94B

 DHR

Danaher Corporation

$145.98B

 NTRA

Natera, Inc.

$47.31B

 IQV

IQVIA Holdings Inc.

$44.07B

 A

Agilent Technologies, Inc.

$42.54B

 IDXX

IDEXX Laboratories, Inc.

$42.18B
View all Diagnostics & Research stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Mettler-Toledo International Inc.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

Visit website →